StemCell Therapy

DUBLIN, June 7, 2022 /PRNewswire/ -- The "Biomarkers Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global biomarkers market is expected to grow at a CAGR of 11.44%.

In-depth Analysis and Data-driven Insights on the Vendor Landscape, Competitive Analysis, and Critical Market Strategies are Included in this Global Biomarkers Market Report

Biomarkers are increasingly useful tools to predict prognosis and response to therapy in cancer patients. Furthermore, it allows to improve understanding of mechanisms of action and resistance to treatment.

GLOBAL BIOMARKERS MARKET SEGMENTATION

Oncology dominated the indication segment because biomarkers are being largely used for cancer research and diagnostics due to its high prevalence worldwide. Biomarkers in the field of oncology has revolutionized the diagnostics and treatment pathways.

Diagnostics dominated the application segment. However, the application of biomarkers in drug discovery & development is expected to grow significantly during the forecast period because biomarkers studies is expected to become an integral part of the drug development process with the aim of developing more effective drugs at a lower cost

Diagnostic biomarker dominated the type of segment as diagnostic biomarker studies have entered a new era where it holds promise for early diagnosis and effective treatment of many diseases.

GEOGRAPHICAL ANALYSIS

North America dominated the geography because biomarkers have been in use highly for diagnostic purposes, drug discovery & development, and precision medicine. The increase in R&D expenditures and fundings for biomarker-driven drug discovery & development and precision medicine is one of the major driving factors in all the regions.

APAC is anticipated to exhibit the highest CAGR of 13.96% during the forecast period. Increasing developments and incorporation of advanced technologies to enhance the biomarker-based testing and increasing demand for biomarkers in drug development and personalized medicine are one of the primary factors in the region.

Story continues

KEY HIGHLIGHTS

Increased Adoption of Biomarkers in Personalized Medicine is driving the global biomarkers market growth. As many healthcare settings have gained interest in personalized/precision medicine, many vendors have increased the studies focusing on identifying biomarkers to provide healthcare system solutions to them.

Increasing focus on digital biomarkers will also drive the global Currently, several digital biomarkers are being tested for feasibility and reliability in Parkinson's and Alzheimer's disease and clinical outcome assessments.

Increasing discovery of epigenetic biomarkers for oncology is also driving the biomarker technologies market. There are more emerging companies increasing their research & development focus on discovering more epigenetics to diagnose various types of cancers.

Technological Advancements in Biomarker Discovery are also positively impacting the biomarkers diagnostics industry. For instance, a recent development in portable biosensors allows rapid, accurate, and on-site detection of biomarkers, which helps prevent disease spread by controlling sources.

VENDOR ANALYSIS

Multiple companies partnering and investing in biomarkers research and development will help the companies to innovate new drugs and reduce the economic burden.

Key Vendors

Other Prominent Vendors

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage4.1 Market Definition4.1.1 Inclusions4.1.2 Exclusions4.1.3 Market Estimation Caveats4.2 Base Year4.3 Scope of the Study4.4 Market Segments4.4.1 Market Segmentation by Indication4.4.2 Market Segmentation by Application4.4.3 Market Segmentation by Type4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats5.1 Key Caveats5.2 Currency Conversion5.3 Market Derivation

6 Market at a Glance

7 Introduction7.1 Overview

8 Market Opportunities & Trends8.1 Increased Adoption of Biomarkers in Personalized Medicine8.2 Increasing Focus on Digital Biomarkers8.3 Increased Discovery of Epigenetic Biomarkers in Oncology

9 Market Growth Enablers9.1 Increase in the Number of Pipeline Biomarkers9.2 Rising Adoption of Biomarkers in Disease Diagnostics9.3 Technological Advancements in Biomarker Discovery

10 Market Restraints10.1 High Cost and Time-Consuming Development10.2 High Number of False Discoveries10.3 Strict Regulations and Ethics for Biomarker Validation & Qualification

11 Market Landscape11.1 Market Overview11.2 Market Size & Forecast11.2.1 Insights by Indication11.2.2 Insights by Application11.2.3 Insights by Type11.2.4 Insights by Geography11.3 Five Forces Analysis

12 Indication12.1 Market Snapshot & Growth Engine12.2 Market Overview12.3 Oncology12.4 Cardiology12.5 Neurology12.6 Immunology12.7 Others

13 Application13.1 Market Snapshot & Growth Engine13.2 Market Overview13.3 Diagnostics13.4 Drug Discovery & Development13.5 Personalized Medicine13.6 Others

14 Type14.1 Market Snapshot & Growth Engine14.2 Market Overview14.3 Diagnostic Biomarkers14.4 Monitoring Biomarkers14.5 Prognostic Biomarkers14.6 Predictive Biomarkers14.7 Susceptibility Biomarkers14.8 Other Biomarkers

15 Geography15.1 Market Snapshot & Growth Engine15.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/vnt809

Media Contact:Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Cision

View original content:https://www.prnewswire.com/news-releases/global-biomarkers-markets-research-2022-2027-increased-adoption-of-biomarkers-in-personalized-medicine--focus-on-digital-biomarkers--increased-discovery-of-epigenetic-biomarkers-in-oncology-301562685.html

SOURCE Research and Markets

Link:
Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased...

This entry was posted on June 8, 2022 at 1:48 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |